REG - Helios Towers PLC - Transaction in Own Shares

Helios TowersAnnouncement

Yesterday 07:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260107:nRSG8903Na&default-theme=true

RNS Number : 8903N  Helios Towers PLC  07 January 2026

Helios Towers plc

Share Buyback Programme - Transactions in Own Securities

 

Helios Towers plc (the "Company") announces that on 6 January 2026 it has
purchased a total of 71,969 of its ordinary shares of £0.01 each ("Ordinary
Shares"), through Jefferies International Limited ("Jefferies") as detailed
below:

 

 Date of purchase:                                                          06/01/2026

 Number of Ordinary Shares purchased:                                       71,969

 Highest price paid per Ordinary Share (pence per Ordinary Share):          165.00p

 Lowest price paid per Ordinary Share (pence per Ordinary Share):           162.60p

 Volume weighted average price paid per Ordinary Share (pence per Ordinary  163.84p
 Share):

 Venue                                                                      LSE

 

The Company intends to cancel the purchased Ordinary Shares and does not
intend to hold any of the purchased Ordinary Shares in treasury.

 

The purchases form part of the Company's share buyback programme as announced
on 6 November 2025. These purchases are the last purchases to be made under
the first tranche of the Programme announced on 6 November 2025. The second
tranche of $25mn will commence on 7 January 2026, under a non-discretionary
agreement with Merrill Lynch International who will act as principal and make
trading decisions independently of the Company, in accordance with pre-set
parameters.

 

Following settlement of the above purchases and cancellation of the purchased
Ordinary Shares, the Company's total number of Ordinary Shares in issue shall
be 1,043,560,105 Ordinary Shares. The figure of 1,043,560,105 Ordinary Shares
may be used by shareholders (and others with notification obligations) as the
denominator for the calculations by which they will determine if they are
required to notify their interest in, or a change to their interest in, the
Company under the Disclosure Guidance and Transparency Rules.

 

In accordance with Article 5(1)(b) of Regulation (EU) No.596/2014 (the Market
Abuse Regulation), as it forms part of domestic law by virtue of the European
Union (Withdrawal) Act 2018, as amended, a detailed breakdown of individual
trades made by Jefferies on behalf of the Company as part of the share buyback
programme is set out below.

 

This announcement does not constitute, or form part of, an offer or any
solicitation of an offer for securities in any jurisdiction.

 

LEI number of Helios Towers plc: 213800DGC7GS4XCHCU30

 

Schedule of Purchases

Aggregate information:

 Trading Venue                Weighted average price (pence per Ordinary Share)  Aggregate volume
 London Stock Exchange (LSE)  163.84p                                            47,526
 Chi-X (CHIX)                 163.84p                                            6,707
 BATE (BATE)                  163.82p                                            13,999
 Turqoise (TRQX)              163.85p                                            1,304
 Aquis (AQXE)                 163.85p                                            2,433

 

Transaction Details:

 Issuer name:        Helios Towers plc
 ISIN:               GB00BJVQC708
 Intermediary name:  Jefferies International Limited
 Intermediary code:  JEFFGB2XXXX
 Time zone:          UKT
 Currency:           GBP

 

 

Individual Transactions:

 

Please see attached PDF for full list of transactions.

 

http://www.rns-pdf.londonstockexchange.com/rns/8903N_1-2026-1-6.pdf
(http://www.rns-pdf.londonstockexchange.com/rns/8903N_1-2026-1-6.pdf)

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  POSAKABBOBKDADK



            Copyright 2019 Regulatory News Service, all rights reserved